Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
55,744,115
-
Share change
-
-18,900,912
-
Total reported value
-
$796,890,075
-
Put/Call ratio
-
16%
-
Price per share
-
$14.32
-
Number of holders
-
257
-
Value change
-
-$259,336,061
-
Number of buys
-
127
-
Number of sells
-
104
Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2022
As of 31 Mar 2022,
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by
257 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,744,115 shares.
The largest 10 holders included
Mondrian Investment Partners LTD, Parametric Portfolio Associates LLC, GOLDMAN SACHS GROUP INC, MACQUARIE GROUP LTD, BANK OF AMERICA CORP /DE/, BlackRock Inc., FMR LLC, NORTHERN TRUST CORP, BRANDES INVESTMENT PARTNERS, LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
262
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.